ACTIRON Dietary Supplement — Class III food recall F-0463-2024
Terminated recall by ActiPharma, Inc., reported 2023-11-29, distributed in PR. FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet foli
| Recall number | F-0463-2024 |
|---|---|
| Product type | Food |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ActiPharma, Inc., Guaynabo, PR, United States |
| Recall initiated | 2023-09-28 |
| Classified | 2023-11-17 |
| Reported by FDA | 2023-11-29 |
| Terminated | 2024-01-16 |
| Distributed | PR |
| Reason classes | labeling |
| UPC / GTIN / UDI-DI | 00363102217104 |
| Lot numbers | 01/26, 13309 |
Product
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Reason for recall
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-0463-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.